Patients with Congenital Low-Flow Vascular Malformation Treated with Low Dose Sirolimus

INTRODUCTION: Patients with congenital vascular malformations often suffer from an impaired quality of life (QoL) because of pain and functional disabilities. Previous studies have shown that the mTOR inhibitor sirolimus can reduce complaints and improve QoL in some patients. High target levels of s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Adv Ther
Main Authors: Harbers, Veroniek E. M., Rongen, Gerard A. P. J. M., van der Vleuten, Carine J. M., Verhoeven, Bas H., de Laat, Peter C. J., van der Horst, Chantal M. A. M., Klein, Willemijn M., Schultze Kool, Leo J., Loo, D. Maroeska W. M. te
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Healthcare 2021
Assuntos:
Case Series
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8190005/
https://ncbi.nlm.nih.gov/pubmed/34003452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-021-01758-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados